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ABSTRACT: Myoepithelial carcinoma (malignant myoepithelioma) of the breast is a rare 
entity and in the male breast it is even rarer. Two cases of benign myoepithelioma in the 
male breast have been reported so far. Here we report, probably the first case of 
Myoepithelial carcinoma in a male breast with clinical features mimicking locally 
advanced breast carcinoma, together with illustration of pathological finding, microscopic 
appearance and management. 
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INTRODUCTIONV 
Myoepithelial carcinoma of the breast remains a 
very rarely reported phenomenon, with only 30 
cases reported in literature, that too only in females. 
Its incidence in the male breast is still rare and no 
case has been reported in the literature so far. This 
is a lesion mainly composed of malignant 
myoepithelial cells. Although histological, 
immunohistochemical and even ultrastructural 
features have been well described. Its definite 
diagnosis based on cytology is still difficult. 
CASE DETAILS 
A 62-year-old male presented with a painless 
swelling in the right breast of two-year duration 
with progressive increase in size and retraction of 
the nipple for last five months. Clinical 
examination revealed a hard nodular swelling in the 
right breast in the subareolar region with retraction 
of the nipple and skin involvement without 
palpable axillary lymphadenopathy. Ultrasound 
examination revealed a round hypoechoic solid 
mass just below the nipple-areola complex of 
20X20 mm size, suspicious of malignancy. FNAC 
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showed malignant cytology. The patient was 
evaluated further by chest X-rays and USG 
Abdomen which did not show any evidence of 
distant metastasis. 
Since FNAC was suggestive of malignancy with 
skin involvement (T4), the patient was taken for 
surgery and Modified Radical Mastectomy was 
done. The patient received six cycles of adjuvant 
chemotherapy FEC regimen (5-flurouracil, 
epirubicin, cyclophoshphamide) followed by 
radiation to the chest wall. 
Gross examination of the resected specimen 
showed a 20X20X15 mm solid mass with 
involvement of the nipple-areola complex (Figure 
1). The mass appeared pale on cut-section with 
central areas of necrosis and an infiltrative growth 
pattern. Histopathological examination revealed 
group of cells composed of haphazard arrangement 
of a mixture of large epithelioid, plasmacytoid and 
spindle cells with increased nuclear cytoplasmic 
ratio, nuclear pleomorphism and several mitotic 
figures (Figure 2). The final impression of HPE 
was myoepithelial carcinoma of breast with no 
axillary lymph node metastasis. Histopathological 
diagnosis was further confirmed by 
immunohistochemistry. Immunohistochemistry 
revealed positive staining with S-100 protein, 
Vimentin, smooth muscle actin (SMA) and 
negative staining for Estrogen and Progesterone 
Receptors. 
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The patient is doing well and there is no evidence 
of local recurrence (Figure 3) as well as distant 
metastasis after six months of follow-up. 
Figure 1: Resected breast tissue with the mass 
Figure 2: Histopathology of the tumor 
Figure 3: Healed scar after modified radical 
mastectomy 
DISCUSSION 
Myoepithelial carcinoma of the breast is extremely 
rare. A limited number of published reports have 
described myoepithelial carcinomas originating in 
the female breast1. Its benign counterpart 
adenomyoepithelioma is also a rare tumor of the 
breast reported for the first time in 19702. 
Malignancy may arise either through malignant 
transformation of one or both the components of 
adenomyoepithelioma of the breast. 
These tumors have been reported in women, 
ranging in age from 26 to 76 years with tumor size 
varying from 1 to 15 cm3. Clinically they present as 
a progressively enlarging, palpable, non-tender, 
laterally located mass4. This case of myoepithelial 
carcinoma is probably the first case, occurring in a 
62 year male, presenting with a slowly increasing 
centrally located nodular painless swelling in the 
right breast with retraction of the nipple and skin 
involvement. 
Metastases from myoepithelial carcinoma are 
described and usually they are hematogenous rather 
than lymphatic and they also appear to be restricted 
to cases of primary tumors with size greater than 
2cm5-9. 
Cytologically, it shows hypercellularity and 
haphazard cellular arrangement with cell 
population mainly composed of spindle, 
epithelioid, plasmacytoid and clear cells10. The 
cellular morphology includes nuclear 
pleomorphism with mitotic figures. Our case did 
not reveal a subpopulation of clear cells but showed 
the other three morphologies. 
Immunohistochemically, cells stain positive for 
antibodies to cytokeratin 8 (CAM 5.2), actin, 
vimentin and cytokeratin 14 and negative for 
cytokeratin 18 and 19. Under electron microscopy, 
well-formed desmosomes and hemidesmosomes 
together with pinocytic vesicles, plentiful rough 
endoplasmic reticulum and 6 nanometer 
microfilaments are seen11. Benign 
adenomyoepithelial lesions variably express 
hormonal receptors in the epithelial component 
where as myoepithelial carcinomas typically are 
completely negative for hormone receptors12. Our 
case also showed positive staining with S-100 
protein, vimentin, SMA and negative for Estrogen 
and Progesterone Receptors. 
The radiological findings of myoepithelial 
carcinomas are usually specific13. In our case both 
mammography and sonography showed features 
suggestive of malignancy such as ill-defined 
margins, distortion of breast parenchyma with 
distal acoustic shadowing. 
Myoepithelial carcinomas in female breasts are 
treated mainly by wide local excision, lymph node 
dissection and adjuvant chemo-radiotherapy14. 
This tumor is prone to local recurrence after 
surgery. The best predictor of local recurrence is an 
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initial close margin of excision. If the excision 
margin is close or having tumor infiltration 
(positive margin), re-excision is advised to gain 
adequate margin. 
Myoepithelial carcinoma of the breast adopts an 
aggressive clinical course with an outcome 
comparable to poorly differentiated 
adenocarcinoma of the breast. Two and five year 
survival is 88% and 55% respectively15. 
The response to chemotherapy and radiotherapy is 
unknown. 
CONCLUSION 
Myoepthelial carcinoma of the breast is a rare 
tumor, which should be suspected, in the 
differential diagnosis of solid breast lesions. 
Myoepithelial carcinoma is difficult to diagnose on 
cytology and core biopsy may be more accurate. 
Histological differential diagnosis includes spindle 
cell carcinoma (negative for myoepithelial marker), 
fibromatosis (positive for beta-catenin) and 
myofibroblastic lesion (no dominant nodule and 
keratin negative). Because of the potential for local 
recurrence following surgery and possibility of 
hematogenous rather than lymphatic metastasis, 
myoepithelial carcinoma should be treated like 
other malignant tumors of breast. 
REFERENCES 
1. Liao KC, Lee WY, Chen MJ. Myoepithelial
carcinoma: a rare neoplasm of the breast.
Breast Care. 2010;5(4):246-9.
2. Hamperl H. The myothelia (myoepithelial
cells). Normal state; regressive changes;
hyperplasia; tumors. Curr Top Pathol.
1970;53:161-220.
3. Michal M, Baumruk L, Burger J, Manhalova
M. Adenomyoepithelioma of the breast with
undifferentiated carcinoma component.
Histopathology. 1994;2:274-6.
4. Tavassoli FA. Myoepithelial lesions of the
breast. Myoepitheliosis, adenomyoepithelioma,
and myoepithelial carcinoma. Am J Surg
Pathol. 1991;15:554–68.
5. Ahmed AA, Heller DS. Malignant
adenomyoepithelioma of the breast with
malignant proliferation of epithelial and 
myoepithelial elements: a case report and 
review of the literature. Arch Pathol Lab Med. 
2000;124:632–6. 
6. Kihara M, Yokomise H, Irie A, Kobayashi S,
et al. Malignant adenomyoepithelioma of the
breast with lung metastases: report of a case.
Surg Today. 2001;31:899-903.
7. Takahashi II, Tashiro H, Wakasugi K, Onohara
T, et al. Malignant adenomyoepithelioma of
the breast: a case with distant metastases.
Breast Cancer. 1999; 6:73-7.
8. Bult P, Verwiel JM, Wobbes T, Kooy-Smits
MM, et al. Malignant adenomyoepithelioma of
the breast with metastasis in the thyroid gland
12 years after excision of the primary
tumor.Case report and review of the literature.
Virchows Arch. 2000;436:158–66.
9. Chen PC, Chen CK, Nicastri AD, Wait RB.
Myoepithelial carcinoma of the breast with
distant metastasis and accompanied by
adenomyoepitheliomas. Histopathology.
1994;24:543–8.
10. Darvishian F, Lin O. Myoepithelial cell-rich
neoplasms: cytologic features of benign and
malignant lesions. Cancer. 2004;102:355-61.
11. Lakhani SR, O'Hare MJ, Monaghan P,
Winehouse J, et al. Malignant myoepithelioma
(myoepithelial carcinoma) of the breast: a
detailed cytokeratin study. J Clin Pathol.
1995;48:164-7.
12. Lakhani S, Ellis I, Schnitt S, Tan P, Van de
Vijver M.  WHO classification of tumors of
the breast. IARC Press, Lyon, France. 2012.
13. Howlett DC, Mason CH, Biswas S, Sangle PD,
et al. Adenomyoepithelioma of the breast:
spectrum of disease with associated imaging
and pathology. AJR Am J Roentgenol.
2003;180(3):799-803.
14. Noronha V, Cooper DL, Higgins SA, Murren
JR, et al. Metastatic myoepithelial carcinoma
of the vulva treated with carboplatin and
paclitaxel. Lancet Oncology. 2006;7(3):270-1.
15. Behranwala KA, Nasiri N, A'Hern R, Gui GP.
Clinical presentation and long-term outcome of
pure myoepithelial carcinoma of the breast.
Eur J Surg Oncol. 2004;30(4):357-61.
